Charles J. Philippin

Charles J. Philippin has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Ulta Beauty, Inc., CALMARE THERAPEUTICS Inc and CSK Auto Corp. Between 4 January 2006 and 12 June 2018, the trades on record add up to 23 filings.

In open-market terms, that means 7 purchases worth €1.2M on one side and 4 sales worth €10.7M on the other. Netting one side against the other leaves €9.5M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 10 share grants and 1 option exercise. 2018 to date brings no purchases and 4 sales.

Half of the purchases are above €97k and half below. Looking at 7 purchases old enough to measure, the stock rose over the following 90 days in 43% of cases; the median change was -19.8%. Past outcomes like these are no guarantee of what comes next.

The latest filing, published on 13 June 2018, reports an open-market sale of €3.4M in Ulta Beauty, Inc. The latest purchase dates back some time: it was published 4,964 days ago, on 21 March 2013. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.